Targeting Oxidative Stress for the Treatment of Liver Fibrosis

Area of Science:

• Hepatology
• Oxidative Stress Research
• Fibrosis Pathogenesis

Background:

• Oxidative stress arises from an imbalance between reactive oxygen species (ROS) production and antioxidant defenses.
• Excessive ROS generation by Kupffer cells (KC) impacts hepatic stellate cells (HSC) and hepatocytes, promoting liver fibrosis.
• ROS contribute to hepatocyte necrosis and apoptosis, exacerbating liver injury and disease progression.

Purpose of the Study:

• To review the critical role of ROS in the pathogenesis of liver fibrosis.
• To discuss novel therapeutic interventions targeting ROS generation pathways.
• To highlight challenges in managing liver fibrosis through oxidative stress modulation.

Main Methods:

• Literature review focusing on the molecular mechanisms of ROS in liver fibrosis.
• Analysis of therapeutic strategies targeting ROS production pathways.
• Discussion of drug development for inhibiting ROS generation.

Main Results:

• ROS-activated HSC deposit excessive extracellular matrix, altering liver architecture and function.
• ROS induce hepatocyte damage, leading to liver injury and end-stage liver disease.
• Novel drugs targeting mitochondrial dysfunction, ER stress, NADPH oxidase (NOX), and Toll-like receptors (TLR) show therapeutic promise.

Conclusions:

• Oxidative stress is a key driver of liver fibrosis progression.
• Targeting ROS generation pathways offers promising therapeutic avenues for liver fibrosis.
• Further research is needed to overcome challenges in clinical application of these therapies.